SEC Form 4 · accession 0001019687-16-006965
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Larry Phillip Raskin
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 18, 2016 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.368 | Jul 6, 2016 | A | 200,000 | A | — | Jul 5, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option is durational-based, and vests and becomes exercisable in twenty-four (24) successive equal monthly installments, commencing on July 6, 2016.